NCT04155593View on ClinicalTrials.gov

In-office Assessment of Voiding Function Following Botox Injection for Overactive Bladder

CompletedOBSERVATIONAL
Enrollment

135

Participants

Timeline

Start Date

November 8, 2019

Primary Completion Date

March 25, 2020

Study Completion Date

July 15, 2020

Conditions
Overactive Bladder
Trial Locations (1)

45220

Cincinnati Urogynecology Associates, Cincinnati

All Listed Sponsors
lead

TriHealth Inc.

OTHER

NCT04155593 - In-office Assessment of Voiding Function Following Botox Injection for Overactive Bladder | Biotech Hunter | Biotech Hunter